
Pere Domingo
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 283 publications
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
Journal: Nature communications
Published: April 27, 2026
Blood vessels at the crossroads: angiogenesis in the intersection of HIV and atherosclerosis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 26, 2026
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 14, 2026
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 02, 2025
CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.
Journal: AIDS (London, England)
Published: November 13, 2025
Community-acquired Pneumonia: Diagnostic Challenges in Non-immunocompromised Patients.
Journal: Journal of thoracic imaging
Published: October 31, 2025
The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization.
Journal: AIDS (London, England)
Published: September 15, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.
Journal: The Lancet. Infectious diseases
Published: September 02, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.
Journal: The Lancet. Infectious diseases
Published: September 02, 2025
Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 16, 2025
Last Updated: 09/26/2026